do insurance companies cover glp-1 drugs MCT2D Patients Face New Barriers for

Additionally, the psychological aspects of BEDincluding emotional regulation difficulties and the functional role of binge eatingmay not be adequately addressed by medication alone

Heres a quick overview: Sometimes, one or more of these medications may be in shortage , making your Rx difficult to fill at the pharmacy

Similarly, anyone with acute kidney injury or ongoing dehydration should delay GLP-1 treatment until their kidneys stabilize and fluid balance improves

Hims & Hers CEO Andrew Dudum said in statement posted on X that the company will continue to offer access to personalized treatments "as allowed by law to meet patient needs." "Were also closely monitoring potential future shortages, as Novo Nordisk stated two weeks ago that it would continue to have 'capacity limitations' and 'expected continued periodic supply constraints and related drug shortage notifications,'" Dudum said

This analysis is a follow-up to research presented by Prime/MRx in 2023, which found that 71 percent of individuals were no longer taking these drugs for weight loss at one year, representing a further 14 percent point decrease in persistence in just one year